Ghulam Md Ashraf Selected Research

aplysinopsin

1/2021

Physicochemical, Interaction & Topological Descriptors vs. hMAO-A Inhibition of Aplysinopsin Analogs: A Boulevard to the Discovery of Semi-synthetic Antidepression Agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ghulam Md Ashraf Research Topics

Disease

47	Alzheimer Disease (Alzheimer's Disease) 07/2022 - 01/2013
32	Neoplasms (Cancer) 11/2022 - 08/2007
31	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2022 - 01/2015
13	Inflammation (Inflammations) 11/2022 - 01/2017
11	Nervous System Diseases (Neurological Disorders) 05/2022 - 01/2015
10	Neuroinflammatory Diseases 06/2022 - 04/2019
10	Dementia (Dementias) 01/2022 - 01/2013
7	Insulin Resistance 05/2022 - 03/2014
6	Infections 06/2022 - 01/2016
6	Cognitive Dysfunction 10/2021 - 01/2019
6	Amyloid Plaque 01/2021 - 01/2019
5	Parkinson Disease (Parkinson's Disease) 02/2022 - 01/2015
5	Body Weight (Weight, Body) 01/2022 - 05/2016
5	Obesity 01/2022 - 01/2017
4	COVID-19 07/2022 - 01/2020
4	Type 2 Diabetes Mellitus (MODY) 05/2022 - 03/2014
4	Pain (Aches) 04/2022 - 01/2019
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2015
4	Stroke (Strokes) 01/2022 - 01/2020
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2017
3	Proteostasis Deficiencies 05/2022 - 01/2018
3	Hyperglycemia 05/2022 - 01/2015
3	Multiple Sclerosis 03/2022 - 01/2017
3	Huntington Disease (Huntington's Disease) 02/2022 - 01/2020
3	Atherosclerosis 01/2022 - 01/2015
3	Disease Progression 01/2022 - 01/2020
3	Glioma (Gliomas) 01/2022 - 01/2017
3	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2015
3	Carcinogenesis 01/2018 - 11/2015
2	Wounds and Injuries (Trauma) 07/2022 - 06/2018
2	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2022 - 01/2019
2	Ischemia 05/2022 - 01/2018
2	Hyperalgesia 04/2022 - 10/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 02/2022 - 01/2020
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2021 - 01/2021
2	Schizophrenia (Dementia Praecox) 01/2021 - 01/2019
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2021 - 01/2021
2	Seizures (Absence Seizure) 04/2020 - 02/2019
2	Sarcoma (Soft Tissue Sarcoma) 01/2019 - 01/2018
2	Rheumatoid Arthritis 01/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2015
20	Pharmaceutical PreparationsIBA 04/2022 - 01/2013
10	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2015
9	Peptides (Polypeptides)IBA 12/2021 - 01/2015
8	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 01/2015
8	Amyloid beta-PeptidesIBA 01/2022 - 01/2019
7	CytokinesIBA 11/2022 - 01/2017
7	AntioxidantsIBA 06/2022 - 05/2016
7	Insulin (Novolin)FDA Link 05/2022 - 03/2014
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2017
6	PhytochemicalsIBA 11/2022 - 07/2020
6	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2017
6	diazonaphthalenedisulfonic acid (NDS)IBA 02/2022 - 08/2019
6	FlavonoidsIBA 01/2022 - 01/2020
5	Biological ProductsIBA 06/2022 - 01/2015
5	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2017
5	Neuroprotective AgentsIBA 01/2022 - 01/2017
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 11/2015
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2014
5	tau Proteins (tau Protein)IBA 01/2021 - 01/2015
4	VaccinesIBA 07/2022 - 01/2018
4	PolyphenolsIBA 05/2022 - 01/2013
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2017
4	Galectins (Galectin)IBA 08/2018 - 08/2007
3	CarbohydratesIBA 05/2022 - 01/2015
3	Estrogens (Estrogen)FDA Link 02/2022 - 01/2019
3	GoldIBA 01/2021 - 01/2015
3	LipidsIBA 01/2020 - 01/2019
3	LigandsIBA 01/2019 - 01/2015
3	EnzymesIBA 01/2018 - 01/2013
3	LectinsIBA 01/2015 - 08/2007
2	Small Interfering RNA (siRNA)IBA 11/2022 - 01/2021
2	CurcuminIBA 09/2022 - 11/2020
2	IronIBA 07/2022 - 12/2021
2	Antiviral Agents (Antivirals)IBA 07/2022 - 01/2018
2	AntigensIBA 06/2022 - 01/2020
2	EpitopesIBA 06/2022 - 11/2017
2	Therapeutic UsesIBA 06/2022 - 01/2021
2	TeaIBA 06/2022 - 01/2015
2	CaspasesIBA 06/2022 - 04/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2022 - 01/2019
2	SteroidsIBA 02/2022 - 01/2021
2	AndrogensIBA 02/2022 - 01/2017
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 02/2022 - 01/2019
2	MetalsIBA 01/2021 - 01/2018
2	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2021
2	PresenilinsIBA 12/2020 - 01/2019
2	Fluoxetine (Prozac)FDA LinkGeneric 04/2020 - 02/2019
2	Raloxifene Hydrochloride (Evista)FDA Link 04/2020 - 02/2019
2	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 01/2019
2	SynucleinsIBA 01/2020 - 01/2018
2	Glutathione (Reduced Glutathione)IBA 10/2019 - 01/2019
2	SolutionsIBA 01/2019 - 01/2016
2	Cholinergic Agents (Cholinergics)IBA 01/2019 - 01/2015

Therapy/Procedure

38	Therapeutics 11/2022 - 08/2007
7	Drug Therapy (Chemotherapy) 04/2022 - 01/2012
3	Immunotherapy 01/2020 - 01/2015
2	Aftercare (After-Treatment) 01/2021 - 01/2019
2	Combination Drug Therapy (Combination Chemotherapy) 05/2020 - 01/2018
2	Radiotherapy 01/2019 - 01/2017